Zealthy semaglutide review
Advertised at $151 and billed at $151 — no gap. Position 4 of 14 on our board.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
About $151 a month with no membership. Another listing where there is simply no gap to report.
The $39 first month lowers the barrier without the usual reversal in month two. From there it is $151 and nothing else.
The numbers
| Zealthy · semaglutide | |
|---|---|
| Advertised | $151/mo |
| Membership | None |
| Billed | $151/mo |
| Advertised-to-billed gap | None |
| Per year | $1,812 |
| Board position | 4 of 14, cheapest first |
Among the lower compounded semaglutide prices with no separate membership stacked on top.
Where the gap is
The $25-a-month figure again — insured, branded, not applicable to cash payers buying the compounded product.
Against the board
About $1,812 a year, second on the semaglutide board behind Coreage Rx at $1,188.
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $99 | $149 | +$50 | +$63/mo |
| Ozari Health | $86 | $86 | none | — |
| Trimi | $99 | $99 | none | +$13/mo |
| Zealthy | $151 | $151 | none | +$65/mo |
| Mochi Health | $99 | $178 | +$79 | +$92/mo |
| Hims & Hers | $79 | $188 | +$109 | +$102/mo |
| PlexusDx | $129 | $189 | +$60 | +$103/mo |
| Eden | $99 | $198 | +$99 | +$112/mo |
How the programme works
Broad telehealth platform with a weight programme that offers both compounded medication and insurance-billed branded prescriptions.
Verified facts
- First month advertised at $39.
- Compounded semaglutide priced from about $151/month.
- Compounded tirzepatide priced from about $216/month.
- Where insurance covers branded semaglutide, patient cost can fall to roughly $25/month.
Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.
For it
- Compounded pricing is competitive without a separate membership charge.
- Will pursue insurance coverage rather than defaulting to cash pay.
- Low-friction $39 first month.
Against it
- The $25/month figure depends entirely on insurance approval and is not a cash price.
- Support is spread across a wide range of unrelated conditions.
Read this bit. The widely quoted $25/month is an insured price. Cash payers should plan on $151+ for semaglutide.
Score
3.5 out of 5 on our rubric, which is fixed before assessment and published on how we rate.
| Criterion | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 3.8 / 5 |
| Price honesty | 20% | 3.5 / 5 |
| Clinical support | 20% | 3.4 / 5 |
| Pharmacy sourcing | 15% | 3.5 / 5 |
| Cancelling | 15% | 3.3 / 5 |
Verdict
Unremarkable in the way this market badly needs more of. No fee games, no teaser whiplash.
More from the desk
- Coreage Rx semaglutide review
Advertised at $99, billed at $149. Position 1 of 14 on our board.
- Ozari Health semaglutide review
Advertised at $86 and billed at $86 — no gap. Position 2 of 14 on our board.
- Trimi semaglutide review
Advertised at $99 and billed at $99 — no gap. Position 3 of 14 on our board.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
- Six fee traps
Every advertised-to-billed gap on our board comes from one of these six structures. Learn them and you can read any of these sites in ninety seconds.
- Where the traps are
The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.